Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Illumina Inc
(NQ:
ILMN
)
131.39
+2.06 (+1.59%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Illumina Inc
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout
April 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Earnings Scheduled For April 27, 2021
April 27, 2021
Companies Reporting Before The Bell • Camden National (NASDAQ:CAC) is projected to report quarterly earnings at $1.01 per share on revenue of $45.73 million. •...
Via
Benzinga
3 Healthcare Stocks About to be Bolstered by Biden's American Rescue Plan
April 24, 2021
The government is going to invest heavily in COVID-19 research and tracking, and these companies are likely to benefit.
Via
The Motley Fool
Exposures
COVID-19
Illumina stock rises on stronger sales, bullish outlook
April 06, 2021
Wells Fargo and Canaccord raised their price targets on Illumina's stock following the preliminary results.
Via
Talk Markets
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
April 24, 2021
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...
Via
Benzinga
Exposures
Product Safety
Illumina, Kartos Therapeutics Team Up To Develop Companion Diagnostic For TP53-Haboring Cancer Indications
April 23, 2021
Illumina Inc (NASDAQ: ILMN) and privately-held Kartos Therapeutics have announced a partnership to develop a next-generation sequencing-based TP53 companion...
Via
Benzinga
The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs
April 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:...
Via
Benzinga
Tesla Hit As The QQQ, SPY And DIA All Fell Today. Here's Why.
April 22, 2021
U.S. indices traded lower Thursday on reports President Biden will propose a capital gains tax for the wealthy of up to 43.4%, which...
Via
Benzinga
The QQQ, SPY And DIA All Fell Today. Here's Why.
April 19, 2021
U.S. indices traded lower Monday amid weakness in tech stocks and potential profit-taking in financials. The Invesco QQ...
Via
Benzinga
3 Biden Healthcare Stocks to Watch
April 17, 2021
The administration's focus on the Affordable Care Act, access to healthcare, and research may accelerate growth for these three stocks.
Via
The Motley Fool
Is Illumina Still a Buy Without the GRAIL Acquisition?
April 15, 2021
Sometimes the most carefully laid plans hit unforeseen snags.
Via
The Motley Fool
Topics
Lawsuit
Exposures
Financial
Legal
The Big Questions for Illumina After Its Q1 Sneak Peek and 2021 Guidance
April 14, 2021
The gene sequencing giant has a couple of key challenges going forward.
Via
The Motley Fool
Ginkgo Bioworks, Which Prints DNA And Creates Genetically Modified Food, Exploring SPAC Deal: Report
April 09, 2021
One of the largest SPACs seeking a target could be nearing a $20 billion deal to bring one of the largest privately-held biotechnology companies public. The SPAC Rumor: Bloomberg...
Via
Benzinga
Biotech Stocks Hit A Snag — Why Experts Say The Heyday Isn't Over
April 09, 2021
Regulatory and drug-pricing worries have knocked biotech stocks off their pedestal. After hitting a high point in February, biotech stocks have fallen 20%.
Via
Investor's Business Daily
Exposures
COVID-19
Stock Market Rally Gains Steam As Apple, Microsoft, Google, Facebook Lead Tech Revival: Weekly Review
April 09, 2021
The Nasdaq fully joined the market rally, as Microsoft, Google and Facebook broke out while Apple and other growth stocks rebounded. The S&P 500 hit ahigh.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
This Unstoppable Stock Doesn't Pay a Dividend Yet, but It Could
April 09, 2021
This giant of the genomic revolution ticks nearly all the boxes dividend investors should look for.
Via
The Motley Fool
Could Illumina's Quest to Acquire GRAIL Fail?
April 09, 2021
The chances are certainly higher now that the deal won't happen.
Via
The Motley Fool
Why Illumina Stock Fell 12.6% in March
April 07, 2021
The biotech was under pressure last month, but it's bouncing back in April.
Via
The Motley Fool
Why Illumina Stock Just Jumped 10%
April 06, 2021
The DNA sequencing company is gearing up to report a big beat later this month.
Via
The Motley Fool
P/E Ratio Insights for Illumina
April 06, 2021
In the current session, Illumina Inc. (NASDAQ:ILMN) is trading at $419.95, after a 9.21% spike. Over the past month, the stock increased by 4.76%, and in the past...
Via
Benzinga
33 Stocks Moving In Tuesday's Mid-Day Session
April 06, 2021
Gainers Scienjoy Holding Corporation (NASDAQ: SJ) shares jumped 67.4% to $16.04 after the company announced a strategic alliance with Snipp to launch a new loyalty and rewards...
Via
Benzinga
51 Biggest Movers From Yesterday
April 07, 2021
Gainers UTime Limited (NASDAQ: UTME) shares jumped 875% to close at $39.00 on Tuesday after the company priced its IPO at $4 per share. Romeo Power, Inc. (NYSE: RMO) climbed 59.6...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.